Clinical and Translational Science Award (UM1 Clinical Trial Optional)
The Clinical and Translational Science Award funds research aimed at improving health outcomes through innovative clinical and translational science.
About this program
The Clinical and Translational Science Award (CTSA) program is designed to enhance the efficiency and effectiveness of clinical and translational research. This grant supports institutions that aim to accelerate the translation of scientific discoveries into practical applications that improve patient care and health outcomes. It is intended for academic institutions, research organizations, and healthcare providers engaged in clinical research. The program fosters collaboration among researchers, clinicians, and community stakeholders to address pressing health challenges and promote health equity. Eligible applicants include universities, medical schools, and other research institutions that demonstrate a commitment to advancing clinical and translational science. The CTSA program encourages the development of innovative methodologies and technologies that can be applied in clinical settings. By providing funding and resources, the program aims to build a robust infrastructure that supports the training of the next generation of clinical researchers and enhances the overall quality of clinical research.
Eligibility
Academic institutions, research organizations, and healthcare providers engaged in clinical research.